Stock PHAS.Q PHASEBIO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar PhaseBio Pharmaceuticals, Inc.

Equities

PHAS.Q

US7172241090

End-of-day quote OTC Markets
Other stock markets
 03:30:00 16/04/2024 am IST 		5-day change 1st Jan Change
0.000001 USD 0.00% Intraday chart for PhaseBio Pharmaceuticals, Inc. 0.00% 0.00%
19/04 First Amended Combined Liquidation Plan and Disclousre Statement Filed by PhaseBio Pharmaceuticals, Inc. CI
07/02 Fifth Motion for Exclusivity Period Extension Approved For PhaseBio Pharmaceuticals, Inc. CI

Chart calendar PhaseBio Pharmaceuticals, Inc.

8eb20cf226bc41b0960201f3641c29.3TNLhXRnuTSP6V4lLPKm0MPUCqPgm4uu4lIvIo6JSnE.rAA81UYm6nLY2BluQaPspYq-PvCSo8XDtRgfb-i-BSiyXxPgQT7wTrqhKQ~d49f5615dadea4f4fcec877f7e2c8ed3

Upcoming events on PhaseBio Pharmaceuticals, Inc.

No events available

Past events on PhaseBio Pharmaceuticals, Inc.

12/08/2022 06:00 pm Interim 2022 Earnings Release
19/05/2022 08:30 pm Annual General Meeting
16/05/2022 06:00 pm Business Update Call
16/05/2022 03:30 pm Q1 2022 Earnings Release
14/04/2022 11:00 pm Needham Virtual Healthcare Conference
02/04/2022 09:45 pm American College of Cardiology Scientific Conference - 403-10
25/03/2022 01:30 am FY 2021 Earnings Release
08/03/2022 11:20 pm Cowen & Co. Health Care Conference - Panel
15/11/2021 11:00 pm REVERSE-IT Phase 3 Trial Results Call
11/11/2021 02:30 am Q3 2021 Earnings Release
13/09/2021 04:30 pm H.C. Wainwright Global Investment Conference
12/08/2021 06:00 pm Interim 2021 Earnings Release
15/07/2021 10:30 pm William Blair Biotech Focus Conference
17/06/2021 06:00 pm Business Update Call
03/06/2021 Annual General Meeting
14/05/2021 01:30 am Q1 2021 Earnings Release
15/04/2021 08:30 pm Needham Healthcare Conference
15/03/2021 09:30 pm Analyst Day
15/03/2021 09:30 pm Investor and Analyst Day
15/03/2021 05:30 pm FY 2020 Earnings Release

Annual results

Fiscal PeriodDecember 2017 2018 2019 2020 2021
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,67
0,41
63.99%		2,36
1,80
31.47%		0,32
0,30
8.11%		10,8
10,5
3.01%
EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
EBIT
Million USD		Released
Forecast
Spread 		0,00


-19,6
-21,1
6.78%		-39,7
-40,3
1.49%		-84,9
-79,6
-6.64%		-107
-106
-1.29%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-23,8
-24,2
1.46%		-39,2
-40,8
3.82%		-98,6
-87,1
-13.23%		-129
-111
-17.16%
Net income
Million USD		Released
Forecast
Spread 		-10,2


-23,8
-28,9
17.53%		-39,2
-39,6
0.77%		-98,6
-88,0
-11.95%		-131
-118
-10.86%
EPS
USD		Released
Forecast
Spread 		-13,8


-2,24
-2,39
6.08%		-1,43
-1,43
0.28%		-3,39
-3,02
-12.1%		-2,98
-2,68
-11.28%
Announcement Date21/09/1826/03/1930/03/2015/03/2124/03/22

Quarterly results

Fiscal PeriodDecember 2020 Q2 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,13
- 		0,00
0,14
- 		0,00
0,05
- 		0,00
0,02
- 		10,3
5,02
105.94%		0,34
1,07
-68.58%		0,16
1,97
-91.96%		0,12
2,33
-94.99%		0,21
0,50
-58.4%
EBITDA
Million USD		Released
Forecast
Spread




















-18,2
-26,9
32.25%		-25,3
-20,6
-22.7%
EBIT
Million USD		Released
Forecast
Spread 		-24,1
-14,7
-64.28%		-20,5
-21,8
5.96%		-26,0
-20,7
-25.7%		-25,6
-23,2
-10.55%		-21,1
-19,3
-9.31%		-28,6
-27,8
-2.8%		-32,1
-28,6
-12.24%		-18,2
-29,8
38.9%		-25,3
-19,1
-32.33%
Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-28,1
-14,9
-89%		-25,1
-21,0
-19.46%		-30,4
-18,9
-60.54%		-27,4
-23,5
-16.46%		-27,1
-24,6
-9.86%		-31,9
-30,5
-4.53%		-43,1
-30,2
-42.51%		-11,1
-32,1
65.34%		-16,7
-20,6
19.21%
Net income
Million USD		Released
Forecast
Spread 		-28,1
-14,7
-91.04%		-25,1
-22,0
-14.51%		-30,4
-19,9
-52.7%		-27,4
-23,5
-16.65%		-28,7
-19,6
-46.59%		-31,9
-29,1
-9.64%		-43,1
-30,2
-42.77%		-11,1
-32,1
65.34%		-16,7
-20,6
19.21%
EPS
USD		Released
Forecast
Spread 		-0,98
-0,51
-92.16%		-0,86
-0,71
-21.47%		-1,03
-0,67
-53.73%		-0,87
-0,73
-18.53%		-0,60
-0,46
-30.43%		-0,66
-0,61
-8.91%		-0,85
-0,58
-47.19%		-0,23
-0,66
65.36%		-0,34
-0,31
-8.8%
Announcement Date11/08/2012/11/2015/03/2113/05/2112/08/2110/11/2124/03/2216/05/2212/08/22

Upcoming sector events for PhaseBio Pharmaceuticals, Inc.

30/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
30/04/2024 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
30/04/2024 WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
01/05/2024 01:35 am EXELIXIS, INC.: Q1 2024 Earnings Release
01/05/2024 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
01/05/2024 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 04:30 pm NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release
More events

Past sector events for PhaseBio Pharmaceuticals, Inc.

Today HITGEN INC.: Q1 2024 Earnings Release (Projected)
Today CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
26/04/2024 INVENTISBIO CO., LIMITED: Q4 2023 Earnings Release
26/04/2024 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release (Projected)
26/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
26/04/2024 SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
26/04/2024 REMEGEN CO., LTD.: Q1 2024 Earnings Release
26/04/2024 01:35 am PTC THERAPEUTICS, INC.: Q1 2024 Earnings Release
25/04/2024 04:00 pm SAGE THERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PHAS.Q Stock
  4. Calendar PhaseBio Pharmaceuticals, Inc.